: We examined
Results
Pancreatic protein level per DNA content Pancreatic protein level per DNA content, an indicator of cell size, was significantly higher in rats receiving camostat (CP, CL) than in the corresponding groups (WP and WL). In addition, pancreatic protein level per DNA content was significantly lower in rats receiving both L-364,718 and camostat (CL) than in rats receiving camostat alone (CP). . Pancreatic protein level per DNA content in WL was lower than that in WP, but this difference was not significant (Fig.2) .
DNA synthesis in pancreatic tissue
Specific radioactivity in groups receiving L-364,718 (WL, CL) was significantly lower than that in the corresponding groups (WP, CP). Specific radioactivity in CP tended to be higher than that in WP, but no significant difference was seen between WL and CL or between WP and CP (Fig.3) . Plasma 
CCK concentration
Plasma CCK concentration in groups receiving camostat (CP, CL) was significantly higher than that in the corresponding groups (WP, WL). No significant difference was In WP and WL, interstitial edema, vacuolation of acinar cells (arrows), and inflammatory cell infiltration (arrowheads) are observed. Inflammatory cell infiltration in WL is more severe than that in WP. In CP and CL, vacuolation of acinar cells (arrow) and inflammatory cell infiltration are slightly seen. The histologic severity of acute pancreatitis is alleviated in groups administered camostat, particularly in CP.
noted between WP and WL or between CP and CL (Fig.4) . (Fig.7) .
Light microscopic examination

Discussion
Administration of large doses of caerulein induces acute edematous pancreatitis in rats, representing a useful acute pancreatitis model because it is relatively easy to produce and the findings are consistent. In investigating the effects of a CCK receptor antagonist on pancreatic regeneration in this model, care is needed concerning timing of CCK receptor antagonist administration since caerulein is an analogue of CCK. Physiologic activity of caerulein could not be detected by bioassay in blood collected 30 min after administration to rats31) . Histologically acute pancreatitis was evident at 12 h after the final caerulein injection, while acinar cell regeneration reached a peak on day 422, 32). Tanaka et a133) reported that the inhibitory effect of L-364,718 on pancreatic exocrine secretion persisted for at least 6 h at a dose of 2 mg/kg body weight, and that the effect of antagonist was similar with oral and intraperitoneal administration.
Based on the results described above, the present study was designed to include L-364,718 injections every 6 h beginning 18 h after the last caerulein injection, while camostat administration began 1 h after the last caerulein injection. Subsequent evaluations were carried out when the rate of DNA synthesis was expected to peak (day 4) . CCK has been shown to exacerbate acute experimental pancreatitis34-3s)' but later becomes an important factor in the regenerative phase. L-364,718 administered twice a day at 1.0 mg/kg for 13 days in rats with caerulein-induced pancreatitis was found to strongly inhibit spontaneous regeneration15). Pancreatic regeneration is also retarded in rats treated with CR-1505 after acute hemorrhagic pancreatitis16). The time point when the role of CCK changes from exacerbatory to pro-regenerative has not been strictly determined. In many reports where a CCK receptor antagonist proved effective in preventing or treating caerulein-induced pancreatitis5, [7] [8] [9] [10] [11] 13, 14) , the CCK receptor antagonist was administered within 3 h of the last caerulein injection. In our present study with delayed administration, inflammatory changes of pancreatitis were histologically more severe in groups with L-364,718 treatment (WL, CL) than in groups without L-364,718 (WP, CP). No therapeutic effects from the CCK receptor antagonist were observed in our study. We used the rate of DNA synthesis, mitotic indices, and labeling inices of acinar cells as indicators of regeneration on day 4. In the group administered water and L-364,718 (WL), all indices were significantly lower, (i.e., regeneration was suppressed) compared with the group without L-364,718 (WP), presumably because of CCK-receptor blockade. An increased pancreatic histologic score also suggested suppression of regeneration. Rats receiving camostat orally and L-364,718 via intraperitoneal injection after caerulein-induced pancreatitis (CL) showed significantly less DNA synthesis (mitotic indices and labeling indices) in acinar cells than the group receiving camostat orally without L-364,718 (CP). Histologically, CL demonstrated a higher inflammatory score and fewer cells undergoing mitosis than CP, indicating suppression of regeneration.
Pancreatic regeneration was strongly suppressed not only in WL but also in CL, suggesting that L-364,718 suppressed regeneration that otherwise would be enhanced by endogenous CCK release in response to camostat. 75 L-364, 718 and Camostat in Acute Pancreatitis
Camostat administration began 1 h after the last caerulein injection. Considering the negative feedback mechanism regulating pancreatic exocrine secretion, such early stimulation of CCK secretion might have been expected to worsen acute pancreatitis. However, the inflammatory score was lower in CP than in WP, while the total histologic score also showed a significant decrease in CP. Otsuki et al reported that even a single administration of camostat, administered as early as 30 min after the final caerulein injection, reduced severity of pancreatitis21). The group receiving both camostat and L-364,718 (CL) showed a somewhat milder inflammatory change than the group given L-364,718 alone (WL), suggesting that the effect of camostat upon caerulein-induced acute pancreatitis was mediated not only by regeneration of acinar cells through CCK, but also passively by other effects such as trypsin inhibition39,40) or enhanced release of endogenous secretin41). Serine protease inhibitors can enter acinar cells, blocking activation of zymogens39). Nakano et al42) described pancreatic regeneration after caerulein-induced pancreatitis followed by treatment with CCK-8 and loxiglumide. They concluded that high doses of a CCK receptor antagonist inhibited pancreatic regeneration even when limited to the first 3 days following induction of pancreatitis. On the other hand, CCK-8 treatment after 3 days of loxiglumide administration greatly increased pancreatic protein, DNA, and enzyme content. CCK appears to play very different roles during the induction phase of acute pancreatitis and during the regeneration phase. How this shift occurs remains to be elucidated. Given in combination, a CCK receptor antagonist and protease inhibitor may promote pancreatic regeneration after acute pancreatitis. Our present observations demonstrate that there may be therapeutic benefit in administrating camostat for the pancreatic repair process. Further studies are needed to determine optimal timing in administering these agents.
